AMYLOIDOSIS
Clinical trials for AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare disease: targeted drug combo tackles AL amyloidosis
Disease control Not yet recruitingThis phase 2 trial is testing whether adding a targeted drug called belantamab mafodotin to standard chemotherapy can improve outcomes for people newly diagnosed with AL amyloidosis, a rare disease where abnormal proteins build up in organs. About 60 adults will receive the drug …
Matched conditions: AMYLOIDOSIS
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 23, 2026 23:34 UTC
-
Heart rehab hope for rare amyloidosis patients
Symptom relief Not yet recruitingThis study tests whether a structured 5-week cardiac rehabilitation program can improve exercise ability and quality of life in 40 adults with cardiac amyloidosis. Participants will undergo supervised aerobic and strength training five days a week, with tests before and after the…
Matched conditions: AMYLOIDOSIS
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 23, 2026 23:35 UTC